Research Topics
| Peter R KoweySummaryAffiliation: Lankenau Institute for Medical Research Country: USA Publications
| Collaborators
|
Detail Information
Publications
Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategiesAdnan Siddiqui
Main Line Health Heart Center and the Lankenau Hospital and Institute for Medical Research, Main Line Health Systems, Wynnewood, Pennsylvania 19096, USA
Curr Opin Cardiol 21:517-25. 2006..This article reviews mechanisms and available therapeutic options for arrhythmias leading to sudden cardiac death in patients with coronary artery disease...
Cardiovascular safety profile of dapoxetine during the premarketing evaluationPeter R Kowey
Division of Cardiovascular Disease, Lankenau Hospital and Institute of Medical Research, Wynnewood, Pennsylvania 19096, USA
Drugs R D 11:1-11. 2011..Findings of the dapoxetine development program demonstrate that dapoxetine is associated with vasovagal-mediated (neurocardiogenic) syncope. No other associated significant cardiovascular adverse events were identified...
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE studyPeter R Kowey
Lankenau Hospital and Institute of Medical Research, Wynnewood, PA, USA
Circulation 124:2649-60. 2011..This study investigated the efficacy and safety of celivarone in preventing implantable cardioverter-defibrillator (ICD) interventions or death...
Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trialPeter R Kowey
Division of Cardiovascular Diseases, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania 19096, USA
JAMA 304:2363-72. 2010..Current pharmacological treatments have limited efficacy and significant adverse events. Limited data from small trials suggest omega-3 polyunsaturated fatty acids may provide a safe, effective treatment option for AF patients...
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective surveyPeter R Kowey
Lankenau Hospital, 100 Lancaster Avenue, Wynnewood, PA, USA
Clin Cardiol 33:172-8. 2010....
Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutterAvinash R Khitri
Lankenau Medical Center and Institute of Medical Research, Wynnewood, PA, USA
J Cardiovasc Electrophysiol 23:462-72. 2012..The purpose of the 2 trials presented here (MAIA and CORYFEE) was to assess celivarone efficacy in the maintenance of sinus rhythm postcardioversion and for the conversion of atrial fibrillation (AF)/atrial flutter (AFL)...
L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulationDonglin Guo
Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
J Cardiovasc Electrophysiol 18:196-203. 2007..AP triangulation has been shown to be an important predictor of drug-induced TdP...
L-type calcium current recovery versus ventricular repolarization: preserved membrane-stabilizing mechanism for different QT intervals across speciesDonglin Guo
Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
Heart Rhythm 5:271-9. 2008..Long QT syndrome is associated with early after-depolarization (EAD) that may result in torsade de pointes (TdP). Interestingly, the corrected QT interval seems to be proportional to body mass across species under physiologic conditions...
Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemiaGan Xin Yan
Main Line Health Heart Center and Lankenau Institute for Medical Research, 100 Lancaster Ave, Wynnewood, PA, 19096, USA
Circulation 110:1036-41. 2004..The present study examined the role of phase 2 reentry in the initiation of VF during early myocardial ischemia...
Calcium-activated chloride current contributes to action potential alternations in left ventricular hypertrophy rabbitDonglin Guo
Main Line Health Heart Ctr, Wynnewood, PA 19096, USA
Am J Physiol Heart Circ Physiol 295:H97-H104. 2008..Our data indicate that abnormal intracellular Ca(2+) fluctuation may exert a strong feedback on the membrane I(Cl,Ca), leading to a beat-to-beat change in the net repolarizing current that manifests as T-wave alternans on the ECG...
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trialPeter R Kowey
Division of Cardiovascular Disease, Lankenau Hospital and Institute of Medical Research, Wynnewood, PA 19096, USA
Circ Arrhythm Electrophysiol 2:652-9. 2009..This study was designed to evaluate the efficacy and safety of vernakalant for the conversion of atrial fibrillation (AF) or atrial flutter (AFL) after cardiac surgery...
Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointesYing Wu
Main Line Health Heart Center, Wynnewood, Pennsylvania, USA
J Cardiovasc Electrophysiol 16:898-904. 2005..CONCLUSIONS: In animal models of TdP, AZD7009 delays ventricular repolarization in a self-limited way associated with a low risk of repolarization-related proarrhythmia...
Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmiasTengxian Liu
Main Line Health Heart Center, Wynnewood, PA 19096, USA
Heart Rhythm 3:948-56. 2006....
Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmiasDonglin Guo
Main Line Health Heart Center and Lankenau Inst, Medical Research, 100 Lancaster Ave, Wynnewood, PA 19096, USA
Am J Physiol Heart Circ Physiol 298:H1375-81. 2010..The I(Na-L) may serve as a potentially useful ionic target for antiarrhythmic drugs for the treatment of atrial arrhythmias in the setting of LVH...
Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventionsOlivera Gojkovic
Lankenau Hospital and Institute of Medical Research, Wynnewood, Philadelphia, Pennsylvania, USA
Heart Rhythm 9:217-224.e2. 2012..However, many patients with ICDs require additional antiarrhythmic therapy to reduce the morbidity associated with recurrent arrhythmia-triggered ICD interventions...
Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytesDonglin Guo
Lankenau Institute for Medical Research and Main Line Health Heart Center, Wynnewood, PA 19096, USA
J Cardiovasc Pharmacol 57:79-85. 2011..HBI-3000 may be a promising antiarrhythmic agent with low proarrhythmic risk...
Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agentsDonglin Guo
Lankenau Institute for Medical Research and Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
Heart Rhythm 8:762-9. 2011..Abnormal rate adaptation of ventricular repolarization is arrhythmogenic. There is controversy on the underlying ionic mechanisms for rate-dependent change in repolarization...
Adjuvant therapy for atrial fibrillationKhaja S Mohammed
Lankenau Hospital, MOB East Suite 558, Wynnewood, PA 19096, USA
Future Cardiol 6:67-81. 2010..This article reviews the data on the role of these agents in the prevention and management of AF as an adjunct to standard therapy...
ECG repolarization waves: their genesis and clinical implicationsThinn Hlaing
Main Line Health Heart Center, Wynnewood, PA 19096, USA
Ann Noninvasive Electrocardiol 10:211-23. 2005..A physiological U wave is thought to be due to delayed repolarization of the Purkinje system...
Overview of the management of atrial fibrillation: what is the current state of the art?Peter R Kowey
Cardiovascular Division, Lankenau Hospital and Medical Research Center, and the Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
J Cardiovasc Electrophysiol 14:S275-80; discussion S280. 2003..The use of warfarin, however, presents its own complications. We conclude that individualization of therapy is paramount when treating AF...
New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?Emily Conway
Division of Cardiovascular Diseases, Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
Am J Cardiol 102:12H-19H. 2008....
Drug therapy for atrial fibrillationEmily L Conway
Lankenau Hospital, Division of Cardiovascular Diseases, Main Line Heart Center, Suite 556, Medical Office Building East, 100 Lancaster Avenue, Wynnewood, PA 19096, USA
Cardiol Clin 27:109-23, ix. 2009..Many new antiarrhythmic drugs are currently being tested in clinical trials. Drugs that target remodeling and inflammation have shown potential in prevention of atrial fibrillation, or as adjunctive therapy...
The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertensionThinn Hlaing
Main Line Health Heart Center, Wynnewood, PA 19096, USA
J Electrocardiol 38:154-8. 2005..01). CONCLUSIONS: There are intrinsic differences in the QT and Tp-e intervals between V4L-V6L and V4R-V6R that are significantly amplified by systemic hypertension but markedly attenuated by pulmonary hypertension...
First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmiaAjay K Joshi
Lankenau Hospital and Institute for Medical Research Main Line Health Heart Center, Wynnewood, Pennsylvania, USA
Am J Cardiol 95:878-81. 2005..MCOT does not require activation by the patient. We report data from the first 100 consecutive patients monitored by this new technology...
Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillationJames A Lally
Lankenau Hospital, Wynnewood, Pennsylvania 19096, USA
J Cardiovasc Electrophysiol 18:1222-8. 2007..The mechanisms of action and clinical trials regarding the effectiveness of these agents in atrial fibrillation prevention are reviewed...
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approachesPeter R Kowey
Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19096, USA
Am J Cardiol 91:33D-38D. 2003..New and evolving therapies and how they might fit into the evolving treatment paradigm are also briefly reviewed...
Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significanceGan Xin Yan
Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
J Am Coll Cardiol 42:401-9. 2003....
Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass graftingPeter R Kowey
Main Line Health Heart Center and the Lankenau Hospital and Institute for Medical Research, Wynnewood, Pennsylvania 19096, USA
Am J Cardiol 94:663-5. 2004..Adverse events and discontinuations for untoward events were equal among the 3 groups...
Pharmacologic therapies for atrial fibrillationHeather M Ross
Main Line Health Heart Center and the Lankenau Hospital and Institute for Medical Research, Wynnewood, PA, USA
Am J Geriatr Cardiol 14:62-7. 2005..A carefully constructed therapeutic regimen can provide effective symptom control and atrial fibrillation management for elderly patients...
DronedaroneChinmay Patel
Main Line Health Heart Center and Lankenau Hospital, Wynnewood, PA 19096, USA
Circulation 120:636-44. 2009..This article will review evidence of safety and effectiveness of dronedarone in patients with atrial fibrillation...
The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoringSteven A Rothman
Lankenau Hospital and Institute for Medical Research Main Line Health Heart Center, Wynnewood, PA, USA
J Cardiovasc Electrophysiol 18:241-7. 2007..The purpose of this study was to compare the relative value of a mobile cardiac outpatient telemetry system (MCOT) with a patient-activated external looping event monitor (LOOP) for symptoms thought to be due to an arrhythmia...
Stroke prevention in atrial fibrillationIlyas Mohammed
Lankenau Hospital and Institute for Medical Research Center, Wynnewood, Pennsylvania, USA
J Cardiovasc Med (Hagerstown) 13:73-85. 2012..This article is intended to help clinicians gain a better understanding of available risk stratification tools and therapies available for prevention of stroke in patients with atrial fibrillation...
Dronedarone: a new treatment for atrial fibrillationJames C Laughlin
Thomas Jefferson University College of Medicine, Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
J Cardiovasc Electrophysiol 19:1220-6. 2008..Dronedarone has proved efficacious without toxic or proarrhythmic effects and has minimal side effects, but remaining concerns exist regarding its use in patients with advanced heart failure...
Selection of drugs in pursuit of a rhythm control strategyPeter R Kowey
Department of Cardiology, Lankenau Hospital, MOBE Suite 558, 100 Lancaster Avenue, Wynnewood, PA 19096, USA
Prog Cardiovasc Dis 48:139-45. 2005..Some newer drugs are currently under investigation and hold promise for improved efficacy and/or more favorable side effect profile and will be mentioned in this article...
Drug therapy for atrial fibrillationSimone Musco
Division of Cardiovascular Diseases, Main Line Heart Center, 556 Medical Office, Building East, 100 Lancaster Avenue, Wynnewood, PA 19096, USA
Med Clin North Am 92:121-41, xi. 2008..New antiarrhythmic drugs are being tested in clinical trials. Drugs that target remodeling and inflammation are being tested for their use as prevention of AF or as adjunctive therapy...
Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction managementTodd J Rudo
Main Line Health and Jefferson Medical College, Wynnewood, Pennsylvania 19096, USA
Clin Cardiol 28:I58-63. 2005..Addition of an aldosterone antagonist is also advised in patients with heart failure. In selected patients with reduced ejection fractions, use of surgical/catheter treatment and device therapy offers further benefits...
Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry)Peter R Kowey
Jefferson Medical College, Philadelphia, Pennsylvania, USA
Am J Cardiol 105:1130-4. 2010..In conclusion, these results suggest that continued physician education of appropriate anticoagulation use in patients with AF is needed...
Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: a blinded validationTengxian Liu
Lankenau Institute for Medical Research and Main Line Health Heart Center, 100 Lancaster Ave, Wynnewood, PA 19096, USA
Heart Rhythm 9:1706-15. 2012..However, the correlation of ECG ventricular waveforms with underlying ion actions is not well established and has been extensively debated...
Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking actionXiaoping Xu
Main Line Health Heart Center, Wynnewood, Pennsylvania 19096, USA
J Cardiovasc Pharmacol 41:414-21. 2003..These effects are self-limited due to SB-237376-induced I(Ca,L) blockade at high concentrations, which may explain its lower proarrhythmic risk than dl-sotalol...
A review of carvedilol arrhythmia data in clinical trialsPeter R Kowey
Division of Cardiovascular Diseases, Main Line Health Heart Center, Wynnewood, PA, Philadelphia, PA 19096, USA
J Cardiovasc Pharmacol Ther 10:S59-68. 2005....
Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapyChristopher Droogan
Department of Cardiology, Main Line Health Heart Center and Lankenau Hospital, 100 Lancaster Avenue, MOBE 356, Wynnewood, PA 19096, USA
Heart Fail Clin 7:195-205, viii. 2011..This article describes data supporting the need for and potential risks and benefits of adjuvant antiarrhythmic drug therapy and examines the benefits and pitfalls of the same in ICD-implanted patients...
Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophyXiaoping Xu
Main Line Health Heart Center, Suite 558, Medical Office Building East, 100 Lancaster Avenue, Wynnewood, PA 19096, USA
Am J Physiol Heart Circ Physiol 283:H664-70. 2002..2 Hz. Pharmacological activation of I(Ks) is a promising new strategy to suppress arrhythmias resulting from excessive AP prolongation in patients with certain forms of long QT syndrome or cardiac hypertrophy and failure...
I've fallen and I can't get upPeter R Kowey
Lankenau Hospital and Main Line Health System, Jefferson Medical College, Philadelphia, PA, USA
Am J Geriatr Cardiol 12:306. 2003
Cardiology patient pages. Ambulatory electrocardiographic recordingPeter R Kowey
Division of Cardiovascular Disease, Lankenau Hospital, Main Line Health Heart Center, Wynnewood, PA, USA
Circulation 108:e31-3. 2003
Case of polymorphic ventricular tachycardia in diphenhydramine poisoningAjay K Joshi
Division of Cardiovascular Diseases, Lankenau Hospital and Institute for Medical Research, Main Line Health Heart Center, Wynnewood, Pennsylvania, USA
J Cardiovasc Electrophysiol 15:591-3. 2004..This case illustrates the variation in repolarization reserve that exists in a free-standing population...
Ischemia versus amiodarone induced polymorphic ventricular tachycardiaHarinder Sharma
Department of Internal Medicine, Main Line Health Heart Center, Lankenau Hospital and Institute of Medical Research, Wynnewood, Pennsylvania, USA
Pacing Clin Electrophysiol 25:1382-4. 2002
